Synapse

← Sophia Zoungas

Papers by Sophia Zoungas

Page 3 · newest first

  1. Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice GuidelineAnnals of Internal Medicine · 2020
  2. Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspectiveEuropean Heart Journal · 2020
  3. Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: many happy returns on investment?European Heart Journal · 2020
  4. Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 DiabetesDiabetes · 2020
  5. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International · 2020
  6. Sodium‐glucose co‐transporter‐2 inhibitors with and without metformin: A meta‐analysis of cardiovascular, kidney and mortality outcomesDiabetes Obesity and Metabolism · 2020
  7. Cost-effectiveness of health technologies in adults with type 1 diabetes: a systematic review and narrative synthesisSystematic Reviews · 2020
  8. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipientsCochrane library · 2020
  9. Cost-effectiveness of dapagliflozin in chronic heart failure: an analysis from the Australian healthcare perspectiveEuropean Journal of Preventive Cardiology · 2020
  10. Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysisDiabetes Care · 2020
  11. Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatmentKidney International · 2020
  12. Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and all‐cause mortality in individuals with type 2 diabetes in the ADVANCE trialJournal of Diabetes · 2020
  13. Development, Relative Validity and Reproducibility of the Aus-SDS (Australian Short Dietary Screener) in Adults Aged 70 Years and aboveNutrients · 2020
  14. Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults with Type 1 DiabetesDiabetes Technology & Therapeutics · 2020
  15. ADVANCE in context: The benefits, risks and feasibility of providing intensive glycaemic control based on gliclazide modified releaseDiabetes Obesity and Metabolism · 2020
  16. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE TrialDiabetes Care · 2020
  17. Young‐onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complicationsDiabetic Medicine · 2020
  18. EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort StudyJMIR Research Protocols · 2020
  19. The Efficacy of Technology in Type 1 Diabetes: A Systematic Review, Network Meta-analysis, and Narrative SynthesisDiabetes Technology & Therapeutics · 2020
  20. Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal studyBMJ Open Diabetes Research & Care · 2020
  21. Polygenic risk scores predict diabetic complications and their response to therapy2019
  22. Association between Heat Exposure and Hospitalization for Diabetes in Brazil during 2000–2015: A Nationwide Case-Crossover StudyEnvironmental Health Perspectives · 2019
  23. The modulating effect of differences in cardiovascular risk factors on major cardiovascular outcomes in glucose-lowering trialsJournal of Hypertension · 2019
  24. Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression ApproachNutrients · 2019
  25. The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative studyPLoS ONE · 2019
  26. Changes in plasma lipids predict pravastatin efficacy in secondary preventionJCI Insight · 2019
  27. Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndromeCardiovascular Diagnosis and Therapy · 2019
  28. Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical OutcomesClinical Journal of the American Society of Nephrology · 2019
  29. A need-based approach to self-management education for adults with co-morbid diabetes and chronic kidney diseaseBMC Nephrology · 2019
  30. Cost-effectiveness of first-line versus delayed use of combination dapagliflozin and metformin in patients with type 2 diabetesScientific Reports · 2019
  31. The Effects of Statins on Physical Activity or Physical Fitness Among Adults: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsJournal of Aging and Physical Activity · 2019
  32. Patterns of Medication Dispensation for Multiple Comorbidities among Older Adults in AustraliaPharmacy · 2018
  33. Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes MellitusHypertension · 2018
  34. Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studiesCardiovascular Research · 2018
  35. Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney diseaseHealth and Quality of Life Outcomes · 2018
  36. Effect of Comorbidity Assessed by the Charlson Comorbidity Index on the Length of Stay, Costs and Mortality among Older Adults Hospitalised for Acute StrokeInternational Journal of Environmental Research and Public Health · 2018
  37. Predictors of first‐year nonadherence and discontinuation of statins among older adults: a retrospective cohort studyBritish Journal of Clinical Pharmacology · 2018
  38. A lifestyle intervention programme for the prevention of Type 2 diabetes mellitus among South Asian women with gestational diabetes mellitus [LIVING study]: protocol for a randomized trialDiabetic Medicine · 2018
  39. Statins for Primary Prevention in Older Adults—Moving Toward Evidence‐Based Decision‐MakingJournal of the American Geriatrics Society · 2018
  40. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseCochrane library · 2018
  41. Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary preventionJCI Insight · 2018
  42. Impact of different glycaemic treatment targets on pregnancy outcomes in gestational diabetesDiabetic Medicine · 2018
  43. Recent Patterns of Multimorbidity Among Older Adults in High-Income CountriesPopulation Health Management · 2018
  44. Comparing two methods for delivering clinical trial informed consent information to older adults: singular versus stepped approachClinical Trials · 2018
  45. Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes AuditBMJ Open · 2018
  46. LDL‐Cholesterol Is the Only Clinically Relevant Biomarker for Atherosclerotic Cardiovascular Disease (ASCVD) RiskClinical Pharmacology & Therapeutics · 2018
  47. Prevalence and Incidence of Statin Use and 3-Year Adherence and Discontinuation Rates Among Older Adults With DementiaAmerican Journal of Alzheimer s Disease & Other Dementias® · 2018
  48. Risk-adjustment of diabetes health outcomes improves the accuracy of performance benchmarkingScientific Reports · 2018
  49. Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE TrialJournal of the American Heart Association · 2018
  50. Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysisSystematic Reviews · 2018